Skip to content
healthcare.dev

Erythromycin

NDC 52536-186, Erythromycin, tablet, delayed release, from Wilshire Pharmaceuticals.

Product NDC
52536-186
Status
Listed
Labeler
Wilshire Pharmaceuticals
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA062298
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52536-186 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERYTHROMYCIN500 mg/1

Pharmacologic classes

Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]

Package NDCNDC-11Package
52536-186-035253601860330 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-186-03)
52536-186-1052536018610100 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-186-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e9b5abbb-2952-44ce-8cbb-415d9be23df4
  • NADAC price for package 52536018603

    GET /v1/drugs/nadac/52536018603

Use it

Look up 52536-186 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52536-186 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52536-186. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.